Post-earnings recap
Reported
Thu, Aug 6, 2020
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Illumina's earnings report showed a miss on EPS, which contributed to a slight decline in stock price by 0.35%. The company is facing challenges due to the ongoing pandemic but remains focused on innovation and long-term growth strategies. Investors may be cautious as there was no guidance provided for future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.62 | N/A | -13.41% |
Management expressed cautious optimism regarding future growth despite current challenges. They highlighted their commitment to innovation in the genomics space.
Management noted ongoing challenges due to the pandemic.
They emphasized a focus on innovation and long-term growth.